Skip to main content
Top
Published in: The Journal of Headache and Pain 3/2011

Open Access 01-06-2011 | Original

Basal cutaneous pain threshold in headache patients

Authors: Maurizio Zappaterra, Simona Guerzoni, Maria Michela Cainazzo, Anna Ferrari, Luigi Alberto Pini

Published in: The Journal of Headache and Pain | Issue 3/2011

Login to get access

Abstract

The aim of this study was to analyze cutaneous pain threshold (CPT) during the interictal phase in headache patients, and the relationships between headache frequency and analgesic use. A consecutive series of 98 headache patients and 26 sex- and age-balanced controls were evaluated. Acute allodynia (AA) was assessed by Jakubowski questionnaire, and interictal allodynia (IA) by a skin test with calibrated monofilaments. AA is widely known as a symptom more present in migraine than in TTH spectrum: in our study this was confirmed only in cases of episodic attacks. When headache index rises towards chronicization, the prevalence of AA increases in both headache spectrums (χ2 13.55; p < 0.01). AA was associated with IA only in cases of chronic headache. When headache becomes chronic, mostly in presence of medication overuse, interictal CPT decreases and IA prevalence increases (χ2 20.44; p < 0.01), with closer association than AA. In MOH patients there were no significant differences depending on the diagnosis of starting headache (migraine or tension type headache) and, in both groups, we found the overuse of analgesics plays an important role: intake of more than one daily drug dramatically reduces the CPT (p < 0.05). Thus, when acute allodynia increases frequency, worsens or appears for the first time in patients with a long-standing history of chronic headache, it could reasonably suggest that the reduction of CPT had started, without using a specific practical skin test but simply by questioning clinical headache history. In conclusion, these results indicate that the role of medication overuse is more important than chronicization in lowering CPT, and suggest that prolonged periods of medication overuse can interfere with pain perception by a reduction of the pain threshold that facilitates the onset of every new attack leading to chronicization.
Literature
1.
go back to reference Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47(5):614–624, 10805332, 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N, 1:STN:280:DC%2BD3c3mtlSrsA%3D%3DCrossRefPubMed Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47(5):614–624, 10805332, 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N, 1:STN:280:DC%2BD3c3mtlSrsA%3D%3DCrossRefPubMed
2.
go back to reference Simone DA, Sorkin LS, Oh U et al (1991) Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 66:228–246, 1919669, 1:STN:280:DyaK38%2FhsVaisw%3D%3DPubMed Simone DA, Sorkin LS, Oh U et al (1991) Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 66:228–246, 1919669, 1:STN:280:DyaK38%2FhsVaisw%3D%3DPubMed
3.
go back to reference Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709, 10908199, 10.1093/brain/123.8.1703CrossRefPubMed Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709, 10908199, 10.1093/brain/123.8.1703CrossRefPubMed
4.
go back to reference Diamond S, Freitag FG, Feoktistov A, Nissan G (2007) Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans. J Headache Pain 8(1):13–18, 17221340, 10.1007/s10194-007-0354-7, 1:CAS:528:DC%2BD2sXjtVSqt7g%3DPubMedCentralCrossRefPubMed Diamond S, Freitag FG, Feoktistov A, Nissan G (2007) Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans. J Headache Pain 8(1):13–18, 17221340, 10.1007/s10194-007-0354-7, 1:CAS:528:DC%2BD2sXjtVSqt7g%3DPubMedCentralCrossRefPubMed
5.
go back to reference Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–982, 9463456, 1:STN:280:DyaK1c7jtVKluw%3D%3DPubMed Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–982, 9463456, 1:STN:280:DyaK1c7jtVKluw%3D%3DPubMed
6.
go back to reference Katsarava Z, Schneewiess S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790, 15007133, 1:STN:280:DC%2BD2c7hslektw%3D%3DCrossRefPubMed Katsarava Z, Schneewiess S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790, 15007133, 1:STN:280:DC%2BD2c7hslektw%3D%3DCrossRefPubMed
7.
go back to reference Fanciullacci M, Cesaris F (2005) Preventing chronicity of migraine. J Headache Pain 6(4):331–333, 16362703, 10.1007/s10194-005-0224-8, 1:CAS:528:DC%2BD28XmvFGmu7Y%3DPubMedCentralCrossRefPubMed Fanciullacci M, Cesaris F (2005) Preventing chronicity of migraine. J Headache Pain 6(4):331–333, 16362703, 10.1007/s10194-005-0224-8, 1:CAS:528:DC%2BD28XmvFGmu7Y%3DPubMedCentralCrossRefPubMed
8.
go back to reference Filatova E, Latysheva N, Kurenkov A (2008) Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 9:295–300, 18690491, 10.1007/s10194-008-0061-7PubMedCentralCrossRefPubMed Filatova E, Latysheva N, Kurenkov A (2008) Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 9:295–300, 18690491, 10.1007/s10194-008-0061-7PubMedCentralCrossRefPubMed
9.
go back to reference Headache Classification Committee of the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 24(Suppl 1):9–160 Headache Classification Committee of the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 24(Suppl 1):9–160
10.
go back to reference Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: proposed revision to the HIS criteria. Headache 34:1–7, 10.1111/j.1526-4610.1994.hed3401001.xCrossRef Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: proposed revision to the HIS criteria. Headache 34:1–7, 10.1111/j.1526-4610.1994.hed3401001.xCrossRef
11.
go back to reference Jakubowski M, Silberstein S, Ashkenazi A, Burstein R (2005) Can allodynic migraine patients be identified interictally using a questionnaire? Neurology 65:1419–1422, 16275830, 10.1212/01.wnl.0000183358.53939.38CrossRefPubMed Jakubowski M, Silberstein S, Ashkenazi A, Burstein R (2005) Can allodynic migraine patients be identified interictally using a questionnaire? Neurology 65:1419–1422, 16275830, 10.1212/01.wnl.0000183358.53939.38CrossRefPubMed
12.
go back to reference Cooke L, Eliasziw M, Becker WJ (2007) Cutaneous allodynia in transformed migraine patients. Headache 47:531–539, 17445102PubMed Cooke L, Eliasziw M, Becker WJ (2007) Cutaneous allodynia in transformed migraine patients. Headache 47:531–539, 17445102PubMed
13.
go back to reference Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression (or for chronic daily headache)—clinical lessons. Headache 46(3):144–146, 10.1111/j.1526-4610.2006.00566.xCrossRef Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression (or for chronic daily headache)—clinical lessons. Headache 46(3):144–146, 10.1111/j.1526-4610.2006.00566.xCrossRef
14.
go back to reference Bigal ME, Lieberman JN, Lipton RB (2006) Obesity and migraine. A population study. Neurology 66(3):545–550, 16354886, 10.1212/01.wnl.0000197218.05284.82CrossRefPubMed Bigal ME, Lieberman JN, Lipton RB (2006) Obesity and migraine. A population study. Neurology 66(3):545–550, 16354886, 10.1212/01.wnl.0000197218.05284.82CrossRefPubMed
15.
go back to reference Lipton RB, Pan J (2004) Is migraine a progressive brain disease? JAMA 291:493–494, 14747508, 10.1001/jama.291.4.493, 1:CAS:528:DC%2BD2cXos12mtA%3D%3DCrossRefPubMed Lipton RB, Pan J (2004) Is migraine a progressive brain disease? JAMA 291:493–494, 14747508, 10.1001/jama.291.4.493, 1:CAS:528:DC%2BD2cXos12mtA%3D%3DCrossRefPubMed
16.
go back to reference Meng ID, Cao L (2007) From migraine to chronic daily headache: the biological basis of headache transformation. Headache 47(8):1251–1258, 17883547, 10.1111/j.1526-4610.2007.00907.xCrossRefPubMed Meng ID, Cao L (2007) From migraine to chronic daily headache: the biological basis of headache transformation. Headache 47(8):1251–1258, 17883547, 10.1111/j.1526-4610.2007.00907.xCrossRefPubMed
17.
go back to reference Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276, 19381087, 10.1097/WCO.0b013e32832b2387CrossRefPubMed Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276, 19381087, 10.1097/WCO.0b013e32832b2387CrossRefPubMed
18.
go back to reference Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016–1017, 11293599, 10.1016/S0140-6736(00)04250-1, 1:STN:280:DC%2BD3M3ivV2jug%3D%3DCrossRefPubMed Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016–1017, 11293599, 10.1016/S0140-6736(00)04250-1, 1:STN:280:DC%2BD3M3ivV2jug%3D%3DCrossRefPubMed
19.
go back to reference De Felice M, Ossipov MH, Wang R et al (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67:325–337, 20373344PubMed De Felice M, Ossipov MH, Wang R et al (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67:325–337, 20373344PubMed
20.
go back to reference Sprenger T, Goadsby PJ (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 16:7–71 Sprenger T, Goadsby PJ (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 16:7–71
21.
go back to reference Bigal ME, Ashina S, Burstein R, Reed L, Buse D, Serrano D, Lipton RB, On behalf of the AMPP Group (2008) Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 70:1525–1533, 18427069, 10.1212/01.wnl.0000310645.31020.b1, 1:STN:280:DC%2BD1c3mvVGmtQ%3D%3DPubMedCentralCrossRefPubMed Bigal ME, Ashina S, Burstein R, Reed L, Buse D, Serrano D, Lipton RB, On behalf of the AMPP Group (2008) Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 70:1525–1533, 18427069, 10.1212/01.wnl.0000310645.31020.b1, 1:STN:280:DC%2BD1c3mvVGmtQ%3D%3DPubMedCentralCrossRefPubMed
22.
go back to reference Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF, American Migraine Prevalence Prevention Advisory Group (2008) Cutaneous allodynia in the migraine population. Ann Neurol 63(2):148–158, 18059010, 10.1002/ana.21211PubMedCentralCrossRefPubMed Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF, American Migraine Prevalence Prevention Advisory Group (2008) Cutaneous allodynia in the migraine population. Ann Neurol 63(2):148–158, 18059010, 10.1002/ana.21211PubMedCentralCrossRefPubMed
23.
go back to reference Apkarian AV, Sosa Y, Sonty S, Levy RM et al (2004) Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24:10410–10415, 15548656, 10.1523/JNEUROSCI.2541-04.2004, 1:CAS:528:DC%2BD2cXhtVGlsL3NCrossRefPubMed Apkarian AV, Sosa Y, Sonty S, Levy RM et al (2004) Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24:10410–10415, 15548656, 10.1523/JNEUROSCI.2541-04.2004, 1:CAS:528:DC%2BD2cXhtVGlsL3NCrossRefPubMed
24.
go back to reference Apkarian AV, Bushnell MC, Treede RD, Zubieta JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9:463–484, 15979027, 10.1016/j.ejpain.2004.11.001CrossRefPubMed Apkarian AV, Bushnell MC, Treede RD, Zubieta JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9:463–484, 15979027, 10.1016/j.ejpain.2004.11.001CrossRefPubMed
25.
go back to reference Critchley HD, Wiens S, Rotshtein P et al (2004) Neural systems supporting interoceptive awareness. Nat Neurosci 7:189–195, 14730305, 10.1038/nn1176, 1:CAS:528:DC%2BD2cXmvVGmug%3D%3DCrossRefPubMed Critchley HD, Wiens S, Rotshtein P et al (2004) Neural systems supporting interoceptive awareness. Nat Neurosci 7:189–195, 14730305, 10.1038/nn1176, 1:CAS:528:DC%2BD2cXmvVGmug%3D%3DCrossRefPubMed
26.
go back to reference Kruit MC, Launer LJ, Overbosch J, Van Buchem MA, Ferrari MD (2009) Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 29:351–359, 19025553, 10.1111/j.1468-2982.2008.01723.x, 1:STN:280:DC%2BD1M7ktlOlsg%3D%3DPubMedCentralCrossRefPubMed Kruit MC, Launer LJ, Overbosch J, Van Buchem MA, Ferrari MD (2009) Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 29:351–359, 19025553, 10.1111/j.1468-2982.2008.01723.x, 1:STN:280:DC%2BD1M7ktlOlsg%3D%3DPubMedCentralCrossRefPubMed
27.
go back to reference Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55:377–391, 17678852, 10.1016/j.neuron.2007.07.012, 1:CAS:528:DC%2BD2sXpsVGltro%3DCrossRefPubMed Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55:377–391, 17678852, 10.1016/j.neuron.2007.07.012, 1:CAS:528:DC%2BD2sXpsVGltro%3DCrossRefPubMed
28.
go back to reference Perrotta A, Serrao M, Rossi P, Bartolo M, Pierelli F, Nappi G (2010) Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalagia 30:272–284, 1:STN:280:DC%2BC3cfmt12rug%3D%3D Perrotta A, Serrao M, Rossi P, Bartolo M, Pierelli F, Nappi G (2010) Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalagia 30:272–284, 1:STN:280:DC%2BC3cfmt12rug%3D%3D
29.
go back to reference Gavva NR, Bannon AW, Surapaneni S et al (2007) The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 27:3366–3374, 17392452, 10.1523/JNEUROSCI.4833-06.2007, 1:CAS:528:DC%2BD2sXktlOjsrs%3DCrossRefPubMed Gavva NR, Bannon AW, Surapaneni S et al (2007) The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 27:3366–3374, 17392452, 10.1523/JNEUROSCI.4833-06.2007, 1:CAS:528:DC%2BD2sXktlOjsrs%3DCrossRefPubMed
30.
go back to reference Cevoli S, Marzocchi N, Capellari S, Scapoli C, Pierangeli G, Grimaldi D, Naldi F, Pini LA, Montagna P, Cortelli P (2010) Lack of association between five serotonin metabolism-related genes and medication overuse headache. J Headache Pain 11(1):53–58, 19936617, 10.1007/s10194-009-0168-5, 1:CAS:528:DC%2BC3cXpsFamtw%3D%3DPubMedCentralCrossRefPubMed Cevoli S, Marzocchi N, Capellari S, Scapoli C, Pierangeli G, Grimaldi D, Naldi F, Pini LA, Montagna P, Cortelli P (2010) Lack of association between five serotonin metabolism-related genes and medication overuse headache. J Headache Pain 11(1):53–58, 19936617, 10.1007/s10194-009-0168-5, 1:CAS:528:DC%2BC3cXpsFamtw%3D%3DPubMedCentralCrossRefPubMed
31.
go back to reference Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2008) Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study. Pain 137:623–630, 18061350, 10.1016/j.pain.2007.10.023, 1:STN:280:DC%2BD1cvlvF2ltA%3D%3DCrossRefPubMed Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2008) Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study. Pain 137:623–630, 18061350, 10.1016/j.pain.2007.10.023, 1:STN:280:DC%2BD1cvlvF2ltA%3D%3DCrossRefPubMed
32.
go back to reference De Felice M, Ossipov MH, Porreca F (2011) Update on medication-overuse headache. Curr Pain Headache Rep 15(1):79–83, 21058047, 10.1007/s11916-010-0155-1PubMedCentralCrossRefPubMed De Felice M, Ossipov MH, Porreca F (2011) Update on medication-overuse headache. Curr Pain Headache Rep 15(1):79–83, 21058047, 10.1007/s11916-010-0155-1PubMedCentralCrossRefPubMed
Metadata
Title
Basal cutaneous pain threshold in headache patients
Authors
Maurizio Zappaterra
Simona Guerzoni
Maria Michela Cainazzo
Anna Ferrari
Luigi Alberto Pini
Publication date
01-06-2011
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 3/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-011-0313-9

Other articles of this Issue 3/2011

The Journal of Headache and Pain 3/2011 Go to the issue